Michael John Sumner - 31 Mar 2026 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Reporting relationship: Chief Medical Officer
Issuer ticker: INO
Reported as of: 31 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Apr 2026, 17:05:12 UTC
Prior SEC filing: 05 Mar 2026
Next SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael John Sumner

Key filing fact

Michael John Sumner filed Form 4 for INOVIO PHARMACEUTICALS, INC. (INO) on 01 Apr 2026.

Key facts

This page summarizes Michael John Sumner's Form 4 filing for INOVIO PHARMACEUTICALS, INC. (INO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2026, 17:05.

Change

Previous filing in this sequence was filed on 05 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001936799 Primary reporting owner

Sumner Michael John

Relationship: Chief Medical Officer
Address: 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING
Signature: /s/ Michael John Sumner
Signature date: 01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INO transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,292
Change %: +14%
Price
Shares after: 34,799
Date: 31 Mar 2026
Ownership: Direct
Footnotes: F1

INO transaction

Common Stock

Tax liability

Transaction value
Shares: -1,223
Change %: -3.5%
Price: $1.74^*
Shares after: 33,576
Date: 31 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INO transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -4,292
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 31 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,292
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026.

Footnote F2

The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.